Quick Takeaways
- JANUS HENDERSON GROUP PLC filed SCHEDULE 13G/A for BENITEC BIOPHARMA INC. Common Stock (BNTC).
- Disclosed ownership: 11%.
- Date of event: 31 Dec 2024.
JANUS HENDERSON GROUP PLC - 31 Dec 2024 SCHEDULE 13G/A Report for BENITEC BIOPHARMA INC. Common Stock (BNTC)
- Filing Manager
- JANUS HENDERSON GROUP PLC
- Reporting Manager
- JANUS HENDERSON GROUP PLC
- Security
- BENITEC BIOPHARMA INC. Common Stock
- Symbol
- BNTC
- Shares outstanding
- 23,154,221 shares
- Disclosed Ownership
- 2,616,427 shares
- Ownership
- 11%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 12:37:15 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 14 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"JANUS HENDERSON GROUP PLC disclosed 11% ownership in BENITEC BIOPHARMA INC. Common Stock (BNTC) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 12:37.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 11% | 2,616,427 | 0 | 2,616,427 | Kristin Mariani | Head of North America Compliance, CCO | |
| Janus Henderson Biotech Innovation Master Fund Ltd | 8.6% | 1,984,639 | 0 | 1,984,639 | Kristin Mariani | Head of North America Compliance, CCO |